首页> 外文期刊>International journal of clinical oncology >Thermoradiotherapy for local control of chest wall invasion in patients with advanced non-small cell lung cancer.
【24h】

Thermoradiotherapy for local control of chest wall invasion in patients with advanced non-small cell lung cancer.

机译:晚期非小细胞肺癌患者的热放射疗法可用于局部控制胸壁浸润。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: We tested the feasibility of hyperthermia combined with concurrent radiotherapy (thermoradiotherapy) for pain relief and local control of non-small cell lung cancer (NSCLC) invading to the chest wall. METHODS: Thirteen patients with advanced NSCLC (eight stage IIIB and five stage IV) and severe pain caused by chest wall invasion of tumor were treated with thermoradiotherapy. During the conventional fractionated radiotherapy period, 8-MHz radiofrequency capacitive hyperthermia was administered once or twice per week for a total of three to nine treatment sessions. Pain relief, objective tumor response, thermometry, and toxicity were evaluated. RESULTS: Twelve of the 13 patients (92%) experienced satisfactory pain relief, and objective tumor shrinkage was observed in 11 of the 13 patients (85%), including complete regression in two. The thermometry parameters of minimum and maximum intratumor temperatures, mean of all intratumor temperatures, and rate of the time during which intratumor temperature was 41 degrees C or higher were 37.6 +/- 0.8 degrees C, 42.4 +/- 0.7 degrees C, 40.3 +/- 0.3 degrees C, and 80.1 +/- 8.6%, respectively. Adverse reactions included local transient skin pain in three patients, but no major toxicity was observed. CONCLUSION: Concurrent thermoradiotherapy for chest wall invasion by advanced NSCLC was feasible, with tolerable toxicity, and it may be effective for pain relief and local tumor control. Further studies comparing thermoradiotherapy and radiotherapy alone for such patient populations are warranted.
机译:背景:我们测试了热疗与同步放疗(热放射疗法)联合用于缓解疼痛和局部控制侵袭胸壁的非小细胞肺癌(NSCLC)的可行性。方法:13例晚期NSCLC患者(八期IIIB和五期IV期)并因胸壁肿瘤浸润引起严重疼痛,接受热放射疗法治疗。在传统的分级放疗期间,每周进行一次或两次8兆赫兹射频电容性热疗,总共进行三至九次治疗。评估疼痛缓解,客观肿瘤反应,体温测定和毒性。结果:13例患者中有12例(92%)疼痛缓解良好,13例患者中有11例(85%)观察到客观的肿瘤缩小,包括2例完全消退。最低和最高肿瘤内温度,所有肿瘤内温度的平均值以及肿瘤内温度达到41摄氏度或更高的时间的测温参数分别为37.6 +/- 0.8摄氏度,42.4 +/- 0.7摄氏度,40.3 +分别为0.3摄氏度和80.1 +/- 8.6%。不良反应包括三例患者的局部暂时性皮肤疼痛,但未观察到重大毒性反应。结论:晚期NSCLC并行热放射疗法治疗胸壁浸润是可行的,具有可耐受的毒性,可能对缓解疼痛和控制局部肿瘤有效。有必要对这些患者人群进行单独的热放射疗法和放射疗法比较研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号